Journal profile · Urology & Nephrology
PROSTATE
ISSN 0270-4137 · eISSN 1097-0045 · Wiley-Liss Inc. · UNITED STATES · Monthly · Founded 1980
PROSTATE: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.63; hybrid open access; APC about USD 4,600; median 92 days to acceptance (90 articles, last 24 months); community-reported acceptance: about 25%; 218 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
PROSTATE is published by Wiley-Liss Inc. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment and Urinary Bladder and Prostate Research, together about 61.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Prostate is a peer-reviewed journal dedicated to original studies of this organ and the male accessory glands. It serves as an international medium for these studies, presenting comprehensive coverage of clinical, anatomic, embryologic, physiologic, endocrinologic, and biochemical studies.
From the journal's Aims & Scope
Research area (LetPub): Urology & Nephrology
Editor-in-chief Shawn LupoldPublisher website
Editorial board by country: 1 in mainland China (about 7%); most named United States 7, Australia 2, Netherlands 2, Mainland China 1, United Kingdom 1 (15 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Prostate Cancer Treatment and ResearchMedicine30.5%
- Prostate Cancer Diagnosis and TreatmentMedicine23.6%
- Urinary Bladder and Prostate ResearchMedicine7.3%
- Hormonal and reproductive studiesMedicine5.2%
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology3%
- Urologic and reproductive health conditionsMedicine2.8%
- Radiopharmaceutical Chemistry and ApplicationsMedicine2.2%
- Cancer, Lipids, and MetabolismBiochemistry, Genetics and Molecular Biology2.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Andrology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.63LetPub ·
- Impact factor (publisher) 2025
- 2.7Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher) 2025
- 5.1Publisher website ·
- SJR 2026-06
- 1.01LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 114LetPub ·
- h-index
- 165OpenAlex ·
- i10-index
- 4,793OpenAlex ·
- 2-year mean citedness
- 2.35OpenAlex ·
- Self-citation rate
- 7.4%LetPub ·
- Share of gold OA articles
- 31.81%LetPub ·
Volume
- Articles per year
- 164LetPub ·
- Articles per year (publisher) 2025
- 178Publisher website ·
- Downloads per year (publisher) 2025
- 360,446Publisher website ·
Articles by year OpenAlex count · 7,795 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 158 | 84 | 35 |
| 2025 | 218 | 101 | 341 |
| 2024 | 199 | 106 | 976 |
| 2023 | 199 | 115 | 1,290 |
| 2022 | 202 | 83 | 2,044 |
| 2021 | 214 | 94 | 2,626 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
92 daysMedian, submission to acceptance · P25–P75 53 days – 127 days
- Acceptance to online
- median 12 days (90 articles)
- Submission to online
- median 107 days
- Sample
- 90 articles with submission and acceptance dates (397 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.5 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
- Acceptance rate (publisher) 2025
- 25%Publisher website ·
- Submission to first decision 2025
- 16 daysPublisher website ·
- Submission to acceptance 2025
- 91 daysPublisher website ·
- Acceptance to publication 2025
- 10 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,600 / EUR 3,840 / GBP 3,040 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- Charged; see the journal's website for the amount
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
Article types accepted1
- rapid communicationThe Editorial Board will consider Rapid Communications upon completion of review. This will be published at no cost to the author. This report should contain th…Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Liss Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1980
- ISSN
- 0270-4137
- Electronic ISSN
- 1097-0045
- Latest issue on the website
- Volume 86, Issue 14 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about PROSTATE
What CAS zone is PROSTATE in?
In the 2025 upgraded edition of the CAS Journal Ranking, PROSTATE is in Zone 3 of Medicine, and in Zone 3 of the minor category Urology & Nephrology / Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of PROSTATE?
The latest impact factor listed by LetPub is 2.63; CiteScore 5.1, h-index 165.
How long does peer review take at PROSTATE?
Based on the dates recorded on 90 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 92 days (interquartile range 53–127 days); authors report an average review time of about 1.5 months; the community-reported acceptance is “about 25%”; the journal's website gives an acceptance rate of 25% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of PROSTATE?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: AMA; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of PROSTATE based?
Of the 15 board members whose country the journal's board page names, 1 (about 7%) are in mainland China; the countries named most often are United States (7), Australia (2) and Netherlands (2). Counted from the institutions listed on the board page; for reference only.
Which databases index PROSTATE?
According to LetPub and DOAJ records, PROSTATE is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is PROSTATE open access, and what is the APC?
PROSTATE is a hybrid journal. For open-access publication: APC about USD 4,600.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .